Search hospitals > Iowa > Ames
Mary Greeley Medical Center
Claim this profileAmes, Iowa 50010
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
209 reported clinical trials
2 medical researchers
Summary
Mary Greeley Medical Center is a medical facility located in Ames, Iowa. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Mary Greeley Medical Center is involved with conducting 209 clinical trials across 372 conditions. There are 2 research doctors associated with this hospital, such as Debra M. Prow and Joseph J. Merchant.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Debra M. ProwMcFarland Clinic PC - Ames4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
125 reported clinical trials
185 drugs studied
Joseph J. MerchantMcFarland Clinic - Ames4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
88 reported clinical trials
141 drugs studied
Clinical Trials running at Mary Greeley Medical Center
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Renal Cell Carcinoma
Melanoma
Cutaneous Melanoma
Pancreatic Cancer
Gastroesophageal Junction Adenocarcinoma
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mary Greeley Medical Center?
Mary Greeley Medical Center is a medical facility located in Ames, Iowa. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Mary Greeley Medical Center is involved with conducting 209 clinical trials across 372 conditions. There are 2 research doctors associated with this hospital, such as Debra M. Prow and Joseph J. Merchant.